Login / Signup

Potent and selective inhibition of SH3 domains with dirhodium metalloinhibitors.

Farrukh VohidovSarah E KnudsenPaul G LeonardJun OhataMichael J WheadonBrian V PoppJohn E LadburyZachary T Ball
Published in: Chemical science (2015)
Src-family kinases (SFKs) play important roles in human biology and are key drug targets as well. However, achieving selective inhibition of individual Src-family kinases is challenging due to the high similarity within the protein family. We describe rhodium(ii) conjugates that deliver both potent and selective inhibition of Src-family SH3 domains. Rhodium(ii) conjugates offer dramatic affinity enhancements due to interactions with specific and unique Lewis-basic histidine residues near the SH3 binding interface, allowing predictable, structure-guided inhibition of SH3 targets that are recalcitrant to traditional inhibitors. In one example, a simple metallopeptide binds the Lyn SH3 domain with 6 nM affinity and exhibits functional activation of Lyn kinase under biologically relevant concentrations (EC50 ∼ 200 nM).
Keyphrases
  • tyrosine kinase
  • emergency department
  • small molecule
  • anti inflammatory
  • drug delivery
  • mass spectrometry